Evidence mapPaperPMID 38246749Full record

SynthesisESC heart failure2024

Triglyceride-glucose index's link to cardiovascular outcomes post-percutaneous coronary intervention in China: a meta-analysis.

ChangXin Sun, LanQing Hu, XiaoYa Li, XiaoNan Zhang, JiYe Chen, DeXiu Li, JingYi Zhang, LongTao Liu, Min Wu

Abstract readMeta-AnalysisReview
In one paragraph

Synthesis in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

ChangXin SunBeijing University of Chinese Medicine, Beijing, China.
LanQing HuNational Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, China.
XiaoYa LiNational Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, China.
XiaoNan ZhangNational Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, China.
JiYe ChenNational Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, China.
DeXiu LiNational Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, China.
JingYi ZhangBeijing University of Chinese Medicine, Beijing, China.
LongTao LiuNational Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, China.
Min WuChina Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beijing, China.

Funding

Capital Health Research and Development of Special Fund 2022-2-4172National Natural Science Foundation of China 81973689Natural Science Foundation of Beijing Municipality 7202176
6 · The paper itself

Abstract

Percutaneous coronary intervention (PCI) addresses myocardial ischaemia, but a significant subset of patients encounter major adverse cardiovascular events (MACE) post-treatment. This meta-analysis investigated the relationship between the post-PCI triglyceride-glucose (TyG) index and MACE. Comprehensive searches of the Embase, PubMed, Cochrane Library, and Web of Science databases were conducted up to 3 March 2023, using relevant keywords. The effect size was determined based on I

Indexed as

Blood GlucosePercutaneous Coronary InterventionTriglyceridesBiomarkersChinaCoronary Artery DiseaseHumansPostoperative ComplicationsBiomarkersBlood GlucoseTriglyceridesAdverse cardiovascular eventsNon‐fatal myocardial infarctionPercutaneous coronary interventionRevascularizationTriglyceride‐glucose index

Identifiers

PMID38246749
PMCPMC11098636

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.